Thus, it is extremely significant to identify auspicious biomarkers which are candidly associated with the prognosis as well as targeting for LUAD immunotherapy.
← all excerpts
High Expression of <i>TACC3</i> Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients.
1
—
—